
EconTalk
Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
Jan 30, 2023
Vinay Prasad, an oncologist and epidemiologist known for his critical take on pharmaceutical regulation, talks about the troubling approval of expensive drugs with minimal benefits. He dives into how profit motives skew oncology drug development and critiques the FDA's shift towards less public health protection. Prasad highlights the ethical dilemmas in healthcare, particularly regarding elderly care, and laments the decline of personal duty in society. His insights urge a reevaluation of what truly matters in healthcare and patient outcomes.
01:09:12
Episode guests
Highlights
AI Chapters
Episode notes
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.